Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey

Fatemeh Salem 1 , Soheila Hekmat 1 , * , Mohammad Reza Aghasadeghi 1 , Foozieh Javadi 1 , Hossein Gholami 2 and Ehsan Mostafavi 3
Authors Information
1 Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, IR Iran
2 Executive deputy of health reference laboratory, Tehran, IR Iran
3 Department of Epidemiology, Pasteur institute of Iran, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2013, 6 (6); e10221
  • Published Online: August 1, 2013
  • Article Type: Research Article
  • Received: January 10, 2013
  • Revised: May 16, 2013
  • Accepted: May 21, 2013
  • DOI: 10.5812/jjm.10221

To Cite: Salem F, Hekmat S, Aghasadeghi M R, Javadi F, Gholami H, et al. Prevalence and Risk Factors of Hepatitis B Virus Genotype D Amongst Inmates in Alborz Province, Iran: A Cross-Sectional Survey, Jundishapur J Microbiol. 2013 ; 6(6):e10221. doi: 10.5812/jjm.10221.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mackie CO, Buxton JA, Tadwalkar S, Patrick DM. Hepatitis B immunization strategies: timing is everything. CMAJ. 2009; 180(2): 196-202[DOI][PubMed]
  • 2. World Health Organization . Hepatitis B.
  • 3. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): 403-6[PubMed]
  • 4. Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon. 2007; 7(1): 3-5
  • 5. Alavian SM. On the occasion of the world hepatitis day: world hepatitis day and our achievements and responsibilities in iran. Int J Prev Med. 2012; 3(7): 437-9[PubMed]
  • 6. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005; 23(19): 2409-23[DOI][PubMed]
  • 7. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008; 82(11): 5657-63[DOI][PubMed]
  • 8. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 9. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology. 2000; 118(3): 554-9[PubMed]
  • 10. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Adeli A, Sabahi F, Abachi M, Azizi M, et al. Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates from Iran. J Med Virol. 2005; 76(3): 318-26[DOI][PubMed]
  • 11. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1): 19-22[PubMed]
  • 12. Javadi AA, Avijgan M, Hafizi M. Prevalence of HBV and HCV infections and associated risk factors in addict prisoners. Iranian J Public Health. 2006; 35(4)
  • 13. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health. 2000; 3(2): 121-6[PubMed]
  • 14. Decker MD, Vaughn WK, Brodie JS, Hutcheson RH, Jr, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984; 150(3): 450-9[PubMed]
  • 15. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ. 2000; 321(7253): 78-82[PubMed]
  • 16. Razzaghi EM, Movaghar AR, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J. 2006; 3: 12[DOI][PubMed]
  • 17. Alavian SM, Keyvani H, Rezai M, Ashayeri N, Sadeghi HM. Preliminary report of hepatitis B virus genotype prevalence in Iran. World J Gastroenterol. 2006; 12(32): 5211-3[PubMed]
  • 18. Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicons. World J Gastroenterol. 2004; 10(21): 3132-6[PubMed]
  • 19. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980; 16(2): 111-20[PubMed]
  • 20. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987; 4(4): 406-25[PubMed]
  • 21. Kumar S, Tamura K, Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 2004; 5(2): 150-63[PubMed]
  • 22. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791): 571-83[DOI][PubMed]
  • 23. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005; 2(1): 50-57[PubMed]
  • 24. Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, et al. Viral hepatitis and HIV infection among injection drug users in a central Iranian City. J Addict Med. 2012; 6(4): 292-6[DOI][PubMed]
  • 25. Kidd-Ljunggren K, Myhre E, Blackberg J. Clinical and serological variation between patients infected with different Hepatitis B virus genotypes. J Clin Microbiol. 2004; 42(12): 5837-41[DOI][PubMed]
  • 26. Clements CJ, Coghlan B, Creati M, Locarnini S, Tedder RS, Torresi J. Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ. 2010; 88(1): 66-73[DOI][PubMed]
  • 27. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004; 47(6): 289-309[DOI][PubMed]
  • 28. Panessa C, Hill WD, Giles E, Yu A, Harvard S, Butt G, et al. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia. J Viral Hepat. 2009; 16(1): 64-73[DOI][PubMed]
  • 29. Fisker N, Pedersen C, Lange M, Nguyen NT, Nguyen KT, Georgsen J, et al. Molecular epidemiology of hepatitis B virus infections in Denmark. J Clin Virol. 2004; 31(1): 46-52[DOI][PubMed]
  • 30. International centre for prison studies . World prison brief.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments